𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Effect of L-dopa on oculogyric crises in a case of dopa-responsive dystonia

✍ Scribed by Paolo Lamberti; Michele de Mari; Giovanni Iliceto; Maria Caldarola; Luigi Serlenga

Publisher
John Wiley and Sons
Year
1993
Tongue
English
Weight
253 KB
Volume
8
Category
Article
ISSN
0885-3185

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Dominant negative effect of GTP cyclohyd
Dominant negative effect of GTP cyclohydrolase I mutations in dopa-responsive hereditary progressive dystonia
✍ Makito Hirano; Takehiko Yanagihara; Dr. Satoshi Ueno πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 945 KB

Hereditary progressive dystonia (HPD) is caused by the mutant gene encoding GTP cyclohydrolase I (GCH). The clinical presentation of this disease varies considerably, and many cases appear to be sporadic. We have previously proposed that this clinical variation may be due to digetential expression o

Neuronal intranuclear inclusion disease:
Neuronal intranuclear inclusion disease: Report on a case originally diagnosed as dopa-responsive dystonia with Lewy bodies
✍ Dominic C. Paviour; Tamas Revesz; Janice L. Holton; Andrew Evans; Jan-Edvin Olss πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 133 KB

## Abstract Neuronal intranuclear inclusion disease (NIID) is a rare neurodegenerative disorder with a heterogeneous clinical picture characterized by the presence of eosinophilic intranuclear inclusions in neuronal and glial cells. We describe a case, reported 12 years ago as dopa‐responsive dysto

Striatal transplantation in a rodent mod
Striatal transplantation in a rodent model of multiple system atrophy: Effects on L-Dopa response
✍ Martin KΓΆllensperger; Nadia Stefanova; Anton Pallua; Zoe Puschban; Georg Dechant πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 166 KB

## Abstract Progressive degeneration of striatal projection neurons is thought to account for the loss of L‐Dopa response observed in the majority of patients with the parkinsonian variant of multiple system atrophy (MSA‐P). Here we have investigated the effects of E14 embryonic striatal allografts

The effects of cisapride on plasma L-dop
The effects of cisapride on plasma L-dopa levels and clinical response in Parkinson's disease
✍ Walter Diaz Neira; Vicenta Sanchez; Maria Angeles Mena; Dr. Justo Garcia de Yebe πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 428 KB πŸ‘ 1 views

Cisapride (CIS) is a prokinetic agent that increases gastrointestinal motility in normal individuals and improves constipation in Parkinson's disease (PD). We studied the effects of CIS on the clinical response and the peripheral pharmacokinetics of orally administered L-dopa given to patients with